Mitchell Herndon was an American teenager from Missouri whose rare neurodegenerative illness later became known as Mitchell Syndrome. His case helped researchers identify a gain-of-function mutation in the ACOX1 gene and connect it with a pattern of neurological decline affecting movement, sensation, hearing and vision.
Herndon died in October 2019 at the age of 19. His parents, Michele and Matt Herndon, later helped establish The Mitchell and Friends Foundation to support families affected by Mitchell Syndrome and to raise money for research.
Illness
Herndon was described by Washington University School of Medicine as having been healthy until around the age of 12, when symptoms began to appear. Over time he experienced episodes that affected walking, sensation below the waist, muscle control, hearing and sight.
His illness was difficult to diagnose because the condition was extremely rare. Genetic work through the Undiagnosed Diseases Network and Baylor College of Medicine identified a variant in ACOX1. Researchers linked the variant to excess ACOX1 activity and damage to nerve-related cells.
ACOX1 Research
The ACOX1 gene is involved in peroxisomal metabolism. Mitchell Syndrome is described by the foundation as a gain-of-function ACOX1 disorder, distinct from classic ACOX1 deficiency. The disorder can lead to harmful build-up of hydrogen peroxide in cells, with damage especially affecting Schwann cells and the myelin that supports nerve signalling.
Research connected Herndon's case with another patient in South Korea who had a similar mutation and clinical pattern. That work helped define the syndrome and gave clinicians a name for a condition that had previously been almost impossible to explain to families.
Treatment Efforts
Herndon received repeated medical care, physical therapy and other support as symptoms relapsed and partially improved at different points. Researchers explored treatment ideas including antioxidant approaches such as N-acetylcysteine amide, often shortened to NACA.
Washington University reported that a possible treatment route was being discussed near the end of his life, but his condition had already worsened severely. His case remained important because it gave researchers clinical detail, genetic data and tissue samples for future work.
Donation and Legacy
Herndon wanted his body to support research. Washington University reported that his family fulfilled that wish by donating his body to a neuromuscular disease research programme at the university.
His tissue samples have been used to study Mitchell Syndrome and related neurodegenerative processes. Washington University also reported that Herndon's contribution was important enough for his name to be listed as an author on the first paper describing the disease.
Mitchell and Friends Foundation
After Herndon's death, his parents began hearing from other families whose children had been diagnosed with Mitchell Syndrome. The Mitchell and Friends Foundation was formed in 2021 to connect those families, explain the condition and support research into treatments.
The foundation has supported work at Washington University and Houston Methodist Hospital. Its public materials describe the syndrome, maintain information for families and track research into possible therapies.
References
Discussion log
Use comments for sourcing notes, corrections, and disputed details.
No comments yet.